AirPROM stands for 'Airway Disease Predicting Outcomes through Patient Specific Computational Modelling'. The AirPROM consortium involves partners from academia, the Biopharma industry, patient/care organisations and small-to-medium enterprises. By encompassing representatives of all stakeholders we aim to integrate and enhance the capacities of all partners to deliver the best possible outcome for people with asthma and chronic obstructive pulmonary disease (COPD).
The AirPROM video highlights the various tests that patients will encounter to help personalise the treatment that they currently receive. The data collected from these tests will be stored in a central database and used to help monitor the risk to future patients.
For more information about the project, please visit:
http://www.airprom.european-lung-foundation.org
Link to this comment:
All Comments (0)